December 27, 2018
3 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: Iluvien reduces central subfield thickness in patients with DME
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
CHICAGO – At the American Academy of Ophthalmology meeting, David Eichenbaum, MD, discusses the PALADIN study and the use of Iluvien (fluocinolone acetonide, Alimera Sciences) in a real-world diabetic macular edema population.